m W PHS PKLN 045S EST 411379 VC IF D 3394 90.19.73 HEARING CLERK FOOD AND DRUG ADMINISTRATION ROOM S-9S n.oo REi DEPARTMENT OF HEALTH, EDUCATION AND WELFARE FOOD AND DRUG ADMINISTRATION (91 CFR PARTS 191,19(5,133) PROPOSED RULEMAKING ON ASBESTOS PARTICULES IN FOOD AND DRUGS AS PRINTED IN FEDERAL REGISTER, VOL. 39, NO. 199, FRIDAY, SEPTEMBER 99, 1973 DEAR SIR* THE ABOVE-MENTIONED MEMORANDUM ON "ASBESTOS PARTICLES IN FOOD AND D R U G S " COVERS THE PRINCI9AL PUFSTION OF A POSSIBLE HEALTH RISK THROUGH PARENTERAL DRUGS CONTAINING ASBESTOS PARTICLES.
refid# np4ygbgGN48aow0MngvRg3rMw1 page
** NORTH AMERICAN FILTRATION COMPANY 7 INDUSTRIAL AVENUE UPPER SADDLE RIVER, N.
refid# B8V3E1qLmyQ3jaV2vxZr3XV1E3 pages
IZ\ Johns-Manville Products Corporation Greenwood Plaza Denver, Colorado 8021 7 (303) 770-1000 July 19, 1974 Hearing Clerk Food & Drug Administration Room 6-86 5600 Fischers Lane Rockville, MD 20852 Dear Sir: On September 28, 1973, the Food & Drug Administration published in the Federal Register a Notice of Proposed Rulemaking relating to asbestos particles in food and drugs (38 F.R. 27076) .
refid# X8wdeLbn2VN4EyyYbRZdVvaL41 page
Pergamon Fit Ctiem.
refid# 3QpZwKg5MJ0LepBXrB4n34Qkn12 pages
Talc Pneumoconiosis by S.H.
refid# zMnBa1j5jneLdwNxRaNNny4n11 pages
MEMORANDUM OF MEETING March 15, 1976 BETWEEN: SUBJECT: FDA Representatives, Division of Cosmetics Technology; Robert M, Schaffner, Ph.D.
refid# 1m6rjxK6rMJg5vOLZYd8n5V53 pages
\ \ --s !
refid# pBbw44R5JVmaqq7pLrbV0OR9a5 pages
DEPARTMENT OF HEALTH, EDUCATION, AN FOOD AND DRUG ADMINISTRATION [21 CFR PARTS 121, 128, 133] ASBESTOS PARTICLES IN FOOD AND DRUGS NOTICE OF PROPOSED RULE MAKING L A ^ 7 0 7 Co The Commissioner of Food and Drugs has received a petition from the Center for Science in the Public Interest, 1779 Church Street, NW., Washington, DC 20036, and the Environmental Defense Fund, 1525 18th Street, NW. , Washington, DC 20036, requesting promulgation of regulations under the Federal Food, Drug, and Cosmetic Act to prohibit the adulteration of food and drugs with asbestos.
refid# K6kjD88zMn6yzX0QLwv3eaO4X34 pages
SECTION II.B
refid# moOXK3mBwaBkZ4GVg7vyg7pb1 page
*------ -- *------------ !
refid# 3QQYDnO6dM0vdyryaGJ8M4QqD35 pages
J MEMORANDUM OF MEETING March 15, 1976 BETWEEN: SUBJECT: FDA Representatives, Division of Cosmetics Technology; Robert M, Schaffner, Ph.D.
refid# oj6OydY1wjMm8k1161kygQxg3 pages
(b) (5) DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION W A SH IN G T O N , D.C. 20204 March 19, 1976 Dr.
refid# 2j4oZEbwDYD575eQq8xEmj59N3 pages
NDTJMr i S A RU / i - V TO : Ar mand R.
refid# MLL7M1nqzNkGEqNkqmXYe0zM3 pages
The Cosmetic, Toiletry and Fragrance Association, Inc. 1133 15th STREET, N.W., WASHINGTON, D.C. 20005 * 202/331-1770 TELEX 89-2673 James H.
refid# kajJ2BRxwebreV8zkG3vnodJ01 page
JOURNAL OF PATHOLOGY, VOL. 158: 7 3 - 8 0 (1 9 8 9 ) SILICA-INDUCED PULMONARY FIBROSIS INVOLVES THE REACTION OF PARTICLES WITH INTERSTITIAL RATHER THAN ALVEOLAR MACROPHAGES D.
refid# LoEXnmEZbwdyEJ55bb6xVB8oQ8 pages